Front. Immunol. Frontiers in Immunology Front. Immunol. 1664-3224 Frontiers Media S.A. 10.3389/fimmu.2023.1226814 Immunology Correction Corrigendum: Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency? KrauszMáté 1 2 3 4 † MitsuikiNoriko 2 † FalconeValeria 5 KompJohanna 6 Posadas-CanteraSara 1 2 6 LorenzHanns-Martin 7 LitzmanJiri 8 WolffDaniel 9 KanariouMaria 10 HeinkeleAnita 11 SpeckmannCarsten 1 2 12 HäckerGeorg 6 HengelHartmut 5 Gámez-DíazLaura 1 2 GrimbacherBodo 1 2 3 13 14 15 * 1Institute for Immunodeficiency, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany 2Center for Chronic Immunodeficiency (CCI), Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany 3Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany 4Faculty of Biology, University of Freiburg, Freiburg, Germany 5Institute of Virology, University Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany 6Institute of Medical Microbiology and Hygiene, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany 7Division of Rheumatology, Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany 8Department of Clinical Immunology and Allergology, St. Anne’s University Hospital in Brno and Medical Faculty, Masaryk University, Brno, Czechia 9Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany 10Department of Immunology and Histocompatibility, Centre for Primary Immunodeficiencies, “Aghia Sophia” Children’s Hospital, Athens, Greece 11Center for Pediatric Rheumatology, Olgahospital, Stuttgart, Germany 12Department of Pediatric Hematology and Oncology, Center for Pediatrics and Adolescent Medicine, Faculty of Medicine, University of Freiburg, Freiburg, Germany 13DZIF – German Center for Infection Research, Satellite Center Freiburg, Freiburg, Germany 14CIBSS – Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany 15RESIST – Cluster of Excellence 2155 to Hannover Medical School, Satellite Center Freiburg, Freiburg, Germany

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

*Correspondence: Bodo Grimbacher, bodo.grimbacher@uniklinik-freiburg.de

†These authors have contributed equally to this work

 02 06 2023 2023 14 1226814 22 05 2023 23 05 2023 Copyright © 2023 Krausz, Mitsuiki, Falcone, Komp, Posadas-Cantera, Lorenz, Litzman, Wolff, Kanariou, Heinkele, Speckmann, Häcker, Hengel, Gámez-Díaz and Grimbacher 2023 Krausz, Mitsuiki, Falcone, Komp, Posadas-Cantera, Lorenz, Litzman, Wolff, Kanariou, Heinkele, Speckmann, Häcker, Hengel, Gámez-Díaz and Grimbacher

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency? By Krausz M, Mitsuiki N, Falcone V, Komp J, Posadas-Cantera S, Lorenz H-M, Litzman J, Wolff D, Kanariou M, Heinkele A, Speckmann C, Häcker G, Hengel H, Gámez-Díaz L and Grimbacher B (2022) Front. Immunol. 13:1011646. doi: 10.3389/fimmu.2022.1011646 cytotoxic T-lymphocyte antigen 4 (CTLA-4) immunodeficencies immune dysregulation inborn errors of immunity (IEI) disease modifiers section-in-acceptance Primary Immunodeficiencies

In the published article, there was an error in the Funding statement. The following funding information is missing: “We acknowledge support by the Open Access Publication Fund of the University of Freiburg.” The correct Funding statement appears below.

Funding

This work was supported by the Deutsche Forsch-ungsgemeinschaft (DFG) IMPATH SFB1160/2_B5. BG receives support by the Deutsche Forschungsgemeinschaft (DFG) SFB1160/2_B5, under Germany’s Excellence Strategy (CIBSS – EXC-2189 – Project ID 390939984, and RESIST – EXC 2155 – Project ID 390874280); by the E-rare program of the EU, managed by the DFG, grant code GR1617/14-1/iPAD; and by the German Federal Ministry of Education and Research (BMBF) through a grant to the German Auto-Immunity Network (GAIN), grant code 01GM1910A. HH is funded by the Deutsche Forschungsgemeinschaft (DFG) through HE2526/9-1. MK is supported by the Deutsche Forschungsgemeinschaft (DFG) SFB1160_2 as clinician scientist associated to IMM-PACT-Program, Faculty of Medicine, University of Freiburg, Freiburg, Germany. We acknowledge support by the Open Access Publication Fund of the University of Freiburg.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

 Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.